The Centers for Disease Control and Prevention will host a panel of experts Tuesday to vote on who should get the first doses of a coronavirus vaccine as a second company, Moderna, asked federal regulators for emergency approval.
The Massachusetts company said Monday that its vaccine was 94% effective in ...
from www.washingtontimes.com stories: Health https://ift.tt/3o8sBTi